Hypercalcaemia, Hypermagnesaemia, Hyperphosphataemia and Hyperaluminaemia in CAPD: Improvement in Serum Biochemistry by Reduction in Dialysate Calcium and Magnesium Concentrations

Alastair J. Hutchison,A. J. O. Were,Helen Boulton,E.B. Mawer,I. Laing,Ram Gokal

Hypercalcaemia, Hypermagnesaemia, Hyperphosphataemia and Hyperaluminaemia in CAPD: Improvement in Serum Biochemistry by Reduction in Dialysate Calcium and Magnesium Concentrations

1996

Alastair J. Hutchison
A. J. O. Were
Helen Boulton
E.B. Mawer
I. Laing
Ram Gokal

Phosphate binders are necessary to control hyperphosphataemia in the majority of dialysis patients. Whilst aluminium salts are efficient phosphate binders, their use is associated with toxic side effe

Keywords:

Calcium
Endocrinology
Dialysis
Hyperphosphatemia
Internal medicine
Side effect
Magnesium
Hypermagnesemia
Biochemistry
Hypercalcaemia
Phosphate
Medicine
Metabolic disorder

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations